Annual Drug Patent Expirations for SOTALOL+HYDROCHLORIDE
Sotalol Hydrochloride is a drug marketed by Altathera Pharms Llc, Apotex, Aurobindo Pharma Usa, Beximco Pharms Usa, Epic Pharma Inc, Impax Pharms, Mylan, Oxford Pharms, Solar Pharm Industries, Teva, Upsher Smith Labs, and Watson Labs and, and is included in seventeen NDAs. It’s accessible from nineteen suppliers. There are two patents defending this drug.
Drug patent litigation for SOTALOL HYDROCHLORIDE.
The generic ingredient in SOTALOL HYDROCHLORIDE is sotalol hydrochloride. Nineteen suppliers are listed for this compound. Extra particulars can be found on the sotalol hydrochloride profile web page.
For extra data on how DrugPatentWatch can assist together with your pharmaceutical enterprise intelligence wants, contact admin@DrugPatentWatch.com or go to www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Initially printed at
